Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Curry-Chisolm IM"'
Autor:
Poe JC; Department of Medicine, Division of Hematologic Malignancies and Cellular Therapy, and., Fang J; Department of Biostatistics and Bioinformatics, Duke University Medical Center, Durham, North Carolina, USA., Zhang D; Duke Cancer Institute, Durham, North Carolina, USA., Lee MR; Department of Biostatistics and Bioinformatics, Duke University Medical Center, Durham, North Carolina, USA., DiCioccio RA; Department of Medicine, Division of Hematologic Malignancies and Cellular Therapy, and., Su H; Department of Medicine, Division of Hematologic Malignancies and Cellular Therapy, and., Qin X; Duke Cancer Institute, Durham, North Carolina, USA., Zhang JY; Department of Dermatology, Duke University Medical Center, Durham, North Carolina, USA., Visentin J; Department of Medicine, Division of Hematologic Malignancies and Cellular Therapy, and.; Department of Immunology and Immunogenetics, Bordeaux University Hospital, Bordeaux, France.; UMR CNRS 5164 ImmunoConcEpT, Bordeaux University, Bordeaux, France., Bracken SJ; Department of Medicine, Division of Rheumatology and Immunology, Duke University Medical Center, Durham, North Carolina, USA., Ho VT; Division of Hematologic Malignancies and Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Wang KS; Division of Hematologic Malignancies and Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Rose JJ; Experimental Transplantation and Immunology Branch, National Cancer Institute, NIH, Bethesda, Maryland, USA., Pavletic SZ; Experimental Transplantation and Immunology Branch, National Cancer Institute, NIH, Bethesda, Maryland, USA., Hakim FT; Experimental Transplantation and Immunology Branch, National Cancer Institute, NIH, Bethesda, Maryland, USA., Jia W; Department of Medicine, Division of Hematologic Malignancies and Cellular Therapy, and., Suthers AN; Department of Medicine, Division of Hematologic Malignancies and Cellular Therapy, and., Curry-Chisolm IM; Department of Medicine, Division of Hematologic Malignancies and Cellular Therapy, and., Horwitz ME; Department of Medicine, Division of Hematologic Malignancies and Cellular Therapy, and.; Duke Cancer Institute, Durham, North Carolina, USA., Rizzieri DA; Department of Medicine, Division of Hematologic Malignancies and Cellular Therapy, and.; Duke Cancer Institute, Durham, North Carolina, USA., McManigle WC; Department of Medicine, Division of Hematologic Malignancies and Cellular Therapy, and., Chao NJ; Department of Medicine, Division of Hematologic Malignancies and Cellular Therapy, and.; Duke Cancer Institute, Durham, North Carolina, USA.; Department of Immunology, Duke University Medical Center, Durham, North Carolina, USA., Cardones AR; Department of Dermatology, Duke University Medical Center, Durham, North Carolina, USA., Xie J; Department of Biostatistics and Bioinformatics, Duke University Medical Center, Durham, North Carolina, USA.; Duke Cancer Institute, Durham, North Carolina, USA., Owzar K; Department of Biostatistics and Bioinformatics, Duke University Medical Center, Durham, North Carolina, USA.; Duke Cancer Institute, Durham, North Carolina, USA., Sarantopoulos S; Department of Medicine, Division of Hematologic Malignancies and Cellular Therapy, and.; Duke Cancer Institute, Durham, North Carolina, USA.; Department of Immunology, Duke University Medical Center, Durham, North Carolina, USA.
Publikováno v:
JCI insight [JCI Insight] 2023 Jun 08; Vol. 8 (11). Date of Electronic Publication: 2023 Jun 08.
Autor:
Jia W; Division of Hematological Malignancies and Cellular Therapy, Department of Medicine and.; Department of Immunology, Duke University School of Medicine and Duke Cancer Institute, Durham, NC., Poe JC; Division of Hematological Malignancies and Cellular Therapy, Department of Medicine and.; Department of Immunology, Duke University School of Medicine and Duke Cancer Institute, Durham, NC., Su H; Division of Hematological Malignancies and Cellular Therapy, Department of Medicine and.; Department of Immunology, Duke University School of Medicine and Duke Cancer Institute, Durham, NC., Anand S; Division of Hematological Malignancies and Cellular Therapy, Department of Medicine and.; Department of Immunology, Duke University School of Medicine and Duke Cancer Institute, Durham, NC., Matsushima GK; Neuroscience Research Center, University of North Carolina at Chapel Hill, Chapel Hill, NC., Rathmell JC; Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, TN.; Vanderbilt Center for Immunobiology, Vanderbilt University Medical Center, Nashville, TN., Maillard I; Division of Hematology/Oncology, Department of Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA., Radojcic V; Division of Hematology and Hematologic Malignancies, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT; and., Imai K; Division of Hematological Malignancies and Cellular Therapy, Department of Medicine and.; Department of Immunology, Duke University School of Medicine and Duke Cancer Institute, Durham, NC., Reyes NJ; Department of Ophthalmology., Cardona DM; Department of Pathology, and., Li Z; Biostatistics and Bioinformatics, Basic Science Department, Duke University Medical Center, Durham, NC., Suthers AN; Division of Hematological Malignancies and Cellular Therapy, Department of Medicine and.; Department of Immunology, Duke University School of Medicine and Duke Cancer Institute, Durham, NC., Curry-Chisolm IM; Division of Hematological Malignancies and Cellular Therapy, Department of Medicine and.; Department of Immunology, Duke University School of Medicine and Duke Cancer Institute, Durham, NC., DiCioccio RA; Division of Hematological Malignancies and Cellular Therapy, Department of Medicine and.; Department of Immunology, Duke University School of Medicine and Duke Cancer Institute, Durham, NC., Saban DR; Department of Ophthalmology., Chen BJ; Division of Hematological Malignancies and Cellular Therapy, Department of Medicine and.; Department of Immunology, Duke University School of Medicine and Duke Cancer Institute, Durham, NC., Chao NJ; Division of Hematological Malignancies and Cellular Therapy, Department of Medicine and.; Department of Immunology, Duke University School of Medicine and Duke Cancer Institute, Durham, NC., Sarantopoulos S; Division of Hematological Malignancies and Cellular Therapy, Department of Medicine and.; Department of Immunology, Duke University School of Medicine and Duke Cancer Institute, Durham, NC.
Publikováno v:
Blood [Blood] 2021 May 06; Vol. 137 (18), pp. 2544-2557.
Assaying Spontaneous Network Activity and Cellular Viability Using Multi-well Microelectrode Arrays.
Autor:
Brown JP; Integrated Systems Toxicology Division, NHEERL, US EPA, MD105-05, Research Triangle Park, NC, 27711, USA., Lynch BS; Integrated Systems Toxicology Division, NHEERL, US EPA, MD105-05, Research Triangle Park, NC, 27711, USA., Curry-Chisolm IM; Integrated Systems Toxicology Division, NHEERL, US EPA, MD105-05, Research Triangle Park, NC, 27711, USA., Shafer TJ; Integrated Systems Toxicology Division, NHEERL, US EPA, MD105-05, Research Triangle Park, NC, 27711, USA. shafer.tim@epa.gov., Strickland JD; Axion Biosystems, Atlanta, GA, USA.; Department of Pharmacology and Toxicology, Michigan State University, E. Lansing, MI, USA.
Publikováno v:
Methods in molecular biology (Clifton, N.J.) [Methods Mol Biol] 2017; Vol. 1601, pp. 153-170.